Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data
Neuraminidase inhibitors (NIs) are stockpiled and recommended by public health agencies for treating and preventing seasonal and pandemic influenza. They are used clinically worldwide.To (1) describe the potential benefits and harms of NIs for influenza in all age groups by reviewing all clinical st...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
NIHR Health Technology Assessment Programme
2016
|